in male runners. Med Sci Sports Exerc. 2009;41(8):1566–72. https://pubmed.ncbi.nlm.nih.gov/19568204/

6647

Ramulu PY, Maul E, Hochberg C, Chan ES, Ferrucci L, Friedman DS. Real-world assessment of physical activity in glaucoma using an accelerometer. Ophthalmology. 2012;119(6):1159–66. https://pubmed.ncbi.nlm.nih.gov/22386950/

6648

Ohguro H, Ohguro I, Katai M, Tanaka S. Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma. Ophthalmologica. 2012;228(1):26–35. https://pubmed.ncbi.nlm.nih.gov/22377796/

6649

McGlynnP. Welcome back black currants: forbidden fruit making a comeback in New York. Cornell Chronicle. https://news.cornell.edu/stories/2006/07/welcome-back-black-currants-forbidden-fruit-making-ny-comeback. Published July 26, 2006. Accessed February 25, 2006.; https://news.cornell.edu/stories/2006/07/welcome-back-black-currants-forbidden-fruit-making-ny-comeback

6650

Sari MD. Ginkgo biloba extract effect on oxidative stress marker malonildialdehyde, redox enzyme gluthation peroxidase, visual field damage, and retinal nerve fiber layer thickness in primary open angle glaucoma. InnoPharm2 Second International Conference on Innovations in Pharmaceutical Medical and Bio Science. Innovare Academic Sciences. http://repository.usu.ac.id/handle/123456789/65446. Published February 11–12, 2017. Accessed September 15, 2022.; https://repository.usu.ac.id/handle/123456789/65446

6651

Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110(2):359–62. https://pubmed.ncbi.nlm.nih.gov/12578781/

6652

Guo X, Kong X, Huang R, et al. Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial. Invest Ophthalmol Vis Sci. 2014;55(1):110–6. https://pubmed.ncbi.nlm.nih.gov/24282229/

6653

Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657–61. https://pubmed.ncbi.nlm.nih.gov/16050865/

6654

Hui F, Tang J, Williams PA, et al. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol. 2020;48(7):903–14. https://pubmed.ncbi.nlm.nih.gov/32721104/

6655

De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM. Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial. JAMA Ophthalmol. 2022;140(1):11–8. https://pubmed.ncbi.nlm.nih.gov/34792559/

6656

Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017;390(10094):600–12. https://pubmed.ncbi.nlm.nih.gov/28242111/

6657

Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017;390(10094):600–12. https://pubmed.ncbi.nlm.nih.gov/28242111/

6658

Stephenson M. Dysphotopsia: not just black and white. Review of Ophthalmology. https://www.reviewofophthalmology.com/article/dysphotopsia-not-just-black-and-white. Published November 7, 2022. Accessed September 15, 2022.; https://www.reviewofophthalmology.com/article/dysphotopsia-not-just-black-and-white

6659

Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017;390(10094):600–12. https://pubmed.ncbi.nlm.nih.gov/28242111/

6660

Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017;390(10094):600–12. https://pubmed.ncbi.nlm.nih.gov/28242111/

6661

Thorn DC, Grosas AB, Mabbitt PD, Ray NJ, Jackson CJ, Carver JA. The structure and stability of the disulfide-linked ¿s-crystallin dimer provide insight into oxidation products associated with lens cataract formation. J Mol Biol. 2019;431(3):483–97. https://pubmed.ncbi.nlm.nih.gov/30552875/

6662

Weikel KA, Garber C, Baburins A, Taylor A. Nutritional modulation of cataract. Nutr Rev. 2014;72(1):30–47. https://pubmed.ncbi.nlm.nih.gov/24279748/

6663

Westenskow PD. Nicotinamide: a novel treatment for age-related macular degeneration? Stem Cell Investig. 2017;4:86. https://pubmed.ncbi.nlm.nih.gov/29167807/

6664

Weikel KA, Garber C, Baburins A, Taylor A. Nutritional modulation of cataract. Nutr Rev. 2014;72(1):30–47. https://pubmed.ncbi.nlm.nih.gov/24279748/

6665

Hah YS, Chung HJ, Sontakke SB, et al. Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study. BMC Ophthalmol. 2017;17(1):121. https://pubmed.ncbi.nlm.nih.gov/28693452/

6666

Mares J. Food antioxidants to prevent cataract. JAMA. 2015;313(10):1048–9. https://pubmed.ncbi.nlm.nih.gov/25756441/

6667

Sideri O, Tsaousis KT, Li HJ, Viskadouraki M, Tsinopoulos IT. The potential role of nutrition on lens pathology: a systematic review and meta-analysis. Surv Ophthalmol. 2019;64(5):668–78. https://pubmed.ncbi.nlm.nih.gov/30878580/

6668

Wei L, Liang G, Cai C, Lv J. Association of vitamin C with the risk of age-related cataract: a meta-analysis. Acta Ophthalmol. 2016;94(3):e170–6. https://pubmed.ncbi.nlm.nih.gov/25735187/

6669

Weikel KA, Garber C, Baburins A, Taylor A. Nutritional modulation of cataract. Nutr Rev. 2014;72(1):30–47. https://pubmed.ncbi.nlm.nih.gov/24279748/

6670

Ma L, Hao Zx, Liu Rr, Yu RB, Shi Q, Pan JP. A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract. Graefes Arch Clin Exp Ophthalmol. 2014;252(1):63–70. https://pubmed.ncbi.nlm.nih.gov/24150707/

6671

Christen WG, Glynn RJ, Sesso HD, et al. Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol. 2010;128(11):1397–405. https://pubmed.ncbi.nlm.nih.gov/21060040/

6672

Kassoff A, Kassoff J, Buehler JA, et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119(10):1439–52. https://pubmed.ncbi.nlm.nih.gov/11594943/

6673

Gritz DC, Srinivasan M, Smith SD, et al. The antioxidants in prevention of cataracts study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006;90(7):847–51. https://pubmed.ncbi.nlm.nih.gov/16556618/

6674

Jiang H, Yin Y, Wu CR, et al. Dietary vitamin and carotenoid intake and risk of age-related cataract. Am J Clin Nutr. 2019;109(1):43–54. https://pubmed.ncbi.nlm.nih.gov/30624584/

6675

Barker FM. Dietary supplementation: effects on visual performance and occurrence of AMD and cataracts. Curr Med Res Opin. 2010;26(8):2011–23. https://pubmed.ncbi.nlm.nih.gov/20590393/

6676

Christen W, Glynn R, Sperduto R, Chew E, Buring J. Age-related cataract in a randomized trial of beta-carotene in women. Ophthalmic Epidemiol. 2004;11(5):401–12. https://pubmed.ncbi.nlm.nih.gov/15590586/

6677

Chew EY, SanGiovanni JP, Ferris FL et al. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol. 2013;131(7):843–50. https://pubmed.ncbi.nlm.nih.gov/23645227/

6678

Maraini G, Williams SL,